BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28099510)

  • 1. Regulation of NUB1 Activity through Non-Proteolytic Mdm2-Mediated Ubiquitination.
    Bonacci T; Audebert S; Camoin L; Baudelet E; Iovanna JL; Soubeyran P
    PLoS One; 2017; 12(1):e0169988. PubMed ID: 28099510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NEDD8 ultimate buster-1 regulates the abundance of TRF1 at telomeres by promoting its proteasomal degradation.
    Jeong YY; Her J; Chung IK
    FEBS Lett; 2016 Jun; 590(12):1776-90. PubMed ID: 27214791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NUB1 promotes cytoplasmic localization of p53 through cooperation of the NEDD8 and ubiquitin pathways.
    Liu G; Xirodimas DP
    Oncogene; 2010 Apr; 29(15):2252-61. PubMed ID: 20101219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1.
    Kamitani T; Kito K; Fukuda-Kamitani T; Yeh ET
    J Biol Chem; 2001 Dec; 276(49):46655-60. PubMed ID: 11585840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NUB1, a NEDD8-interacting protein, is induced by interferon and down-regulates the NEDD8 expression.
    Kito K; Yeh ET; Kamitani T
    J Biol Chem; 2001 Jun; 276(23):20603-9. PubMed ID: 11259415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1.
    Tanji K; Tanaka T; Mori F; Kito K; Takahashi H; Wakabayashi K; Kamitani T
    Am J Pathol; 2006 Aug; 169(2):553-65. PubMed ID: 16877356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NUB1-mediated targeting of the ubiquitin precursor UbC1 for its C-terminal hydrolysis.
    Tanaka T; Yeh ET; Kamitani T
    Eur J Biochem; 2004 Mar; 271(5):972-82. PubMed ID: 15009209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity.
    Xirodimas DP; Saville MK; Bourdon JC; Hay RT; Lane DP
    Cell; 2004 Jul; 118(1):83-97. PubMed ID: 15242646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A lysine-to-arginine mutation on NEDD8 markedly reduces the activity of cullin RING E3 ligase through the impairment of neddylation cascades.
    Sui Y; Liu Y; Xu G
    Biochem Biophys Res Commun; 2015 Jun; 461(4):653-8. PubMed ID: 25918018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Src phosphorylation converts Mdm2 from a ubiquitinating to a neddylating E3 ligase.
    Batuello CN; Hauck PM; Gendron JM; Lehman JA; Mayo LD
    Proc Natl Acad Sci U S A; 2015 Feb; 112(6):1749-54. PubMed ID: 25624478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of NEDD8 and FAT10 ligase activities through the degrading enzyme NEDD8 ultimate buster 1: A potential anticancer approach.
    Tan KL; Pezzella F
    Oncol Lett; 2016 Dec; 12(6):4287-4296. PubMed ID: 28101194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific inhibition of Mdm2-mediated neddylation by Tip60.
    Dohmesen C; Koeppel M; Dobbelstein M
    Cell Cycle; 2008 Jan; 7(2):222-31. PubMed ID: 18264029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNF12 promotes p53-dependent cell growth suppression and apoptosis by targeting MDM2 for destruction.
    Gao K; Wang C; Jin X; Xiao J; Zhang E; Yang X; Wang D; Huang H; Yu L; Zhang P
    Cancer Lett; 2016 May; 375(1):133-141. PubMed ID: 26926424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of NUB1 as a suppressor of mutant Huntington toxicity via enhanced protein clearance.
    Lu B; Al-Ramahi I; Valencia A; Wang Q; Berenshteyn F; Yang H; Gallego-Flores T; Ichcho S; Lacoste A; Hild M; Difiglia M; Botas J; Palacino J
    Nat Neurosci; 2013 May; 16(5):562-70. PubMed ID: 23525043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of NUB1 with the proteasome subunit S5a.
    Tanji K; Tanaka T; Kamitani T
    Biochem Biophys Res Commun; 2005 Nov; 337(1):116-20. PubMed ID: 16171779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
    Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
    J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDM2 E3 ligase-mediated ubiquitination and degradation of HDAC1 in vascular calcification.
    Kwon DH; Eom GH; Ko JH; Shin S; Joung H; Choe N; Nam YS; Min HK; Kook T; Yoon S; Kang W; Kim YS; Kim HS; Choi H; Koh JT; Kim N; Ahn Y; Cho HJ; Lee IK; Park DH; Suk K; Seo SB; Wissing ER; Mendrysa SM; Nam KI; Kook H
    Nat Commun; 2016 Feb; 7():10492. PubMed ID: 26832969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitination of p53 at multiple sites in the DNA-binding domain.
    Chan WM; Mak MC; Fung TK; Lau A; Siu WY; Poon RY
    Mol Cancer Res; 2006 Jan; 4(1):15-25. PubMed ID: 16446403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scaffold protein FHL2 facilitates MDM2-mediated degradation of IER3 to regulate proliferation of cervical cancer cells.
    Jin H; Lee K; Kim YH; Oh HK; Maeng YI; Kim TH; Suh DS; Bae J
    Oncogene; 2016 Sep; 35(39):5106-18. PubMed ID: 26973248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy induces NEDP1-mediated destabilization of MDM2.
    Watson IR; Li BK; Roche O; Blanch A; Ohh M; Irwin MS
    Oncogene; 2010 Jan; 29(2):297-304. PubMed ID: 19784069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.